1. A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials. (November 2018) Authors: Ingles Garces, Alvaro H.; Ang, Joo Ern; Ameratunga, Malaka; Chénard-Poirier, Maxime; Dolling, David; Diamantis, Nikolaos; Seeramreddi, Satyanarayana; Sundar, Raghav; de Bono, Johann; Lopez, Juanita; Banerji, Udai Journal: European journal of cancer Issue: Volume 104(2018) Page Start: 32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A study of motivations and expectations of patients seen in phase 1 oncology clinics. Issue 22 (26th September 2016) Authors: Dolly, Saoirse O.; Kalaitzaki, Eleftheria; Puglisi, Martina; Stimpson, Sarah; Hanwell, Janet; Fandos, Sonia Serrano; Stapleton, Sarah; Ansari, Thushara; Peckitt, Clare; Kaye, Stan; Lopez, Juanita; Yap, Timothy A.; van der Graaf, Winette; de Bono, Johann; Banerji, Udai Journal: Cancer Issue: Volume 122:Issue 22(2016) Page Start: 3501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Issue 10024 (19th March 2016) Authors: James, Nicholas D; Sydes, Matthew R; Clarke, Noel W; Mason, Malcolm D; Dearnaley, David P; Spears, Melissa R; Ritchie, Alastair W S; Parker, Christopher C; Russell, J Martin; Attard, Gerhardt; de Bono, Johann; Cross, William; Jones, Rob J; Thalmann, George; Amos, Claire; Matheson, David; Millman,... Journal: Lancet Issue: Volume 387:Issue 10024(2016) Page Start: 1163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies. Issue 7 (22nd July 2021) Authors: Roulstone, Victoria; Mansfield, David; Harris, Robert J; Twigger, Katie; White, Christine; de Bono, Johann; Spicer, James; Karagiannis, Sophia N; Vile, Richard; Pandha, Hardev; Melcher, Alan; Harrington, Kevin Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease. (19th March 2021) Authors: Suzuki, Hiroyoshi; Castellano, Daniel; de Bono, Johann; Sternberg, Cora N; Fizazi, Karim; Tombal, Bertrand; Wülfing, Christian; Foster, Meredith C; Ozatilgan, Ayse; Geffriaud-Ricouard, Christine; de Wit, Ronald Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 8(2021) Page Start: 1287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Circulating cell-free DNA: Translating prostate cancer genomics into clinical care. (April 2020) Authors: Gasi Tandefelt, Delila; de Bono, Johann Journal: Molecular aspects of medicine Issue: Volume 72(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Corrigendum to 'Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer' [European Journal of Cancer 76 (2017) 36–44]. (August 2017) Authors: Massard, Christophe; Chi, Kim Nguyen; Castellano, Daniel; de Bono, Johann; Gravis, Gwenaelle; Dirix, Luc; Machiels, Jean-Pascal; Mita, Alain; Mellado, Begoña; Turri, Sabine; Maier, Joan; Csonka, Denes; Chakravartty, Arunava; Fizazi, Karim Journal: European journal of cancer Issue: Volume 81(2017) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302. (July 2022) Authors: Wilson, Brooke E.; Armstrong, Andrew J.; de Bono, Johann; Sternberg, Cora N.; Ryan, Charles J.; Scher, Howard I.; Smith, Matthew R.; Rathkopf, Dana; Logothetis, Christopher J.; Chi, Kim N.; Jones, Robert J.; Saad, Fred; De Porre, Peter; Tran, NamPhuong; Hu, Peter; Gillessen, Silke; Carles, Joan; ... Journal: European journal of cancer Issue: Volume 170(2022) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Enzalutamide in European and North American men participating in the AFFIRM trial. (23rd October 2014) Authors: Merseburger, Axel S.; Scher, Howard I.; Bellmunt, Joaquim; Miller, Kurt; Mulders, Peter F.A.; Stenzl, Arnulf; Sternberg, Cora N.; Fizazi, Karim; Hirmand, Mohammad; Franks, Billy; Haas, Gabriel P.; de Bono, Johann; de Wit, Ronald Journal: BJU international Issue: Volume 115:Number 1(2015:Jan.) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Heterogeneity of advanced prostate cancer: clinical implications of genomics. Issue 5 (27th September 2017) Authors: Linch, Mark; de Bono, Johann Journal: Trends in urology & men's health Issue: Volume 8:Issue 5(2017) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗